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Neurodegenerative disorders such as Alzheimer’s disease are characterized by 
damage to neural cells causing widespread neurological deficits. Historically, these 
diseases were deemed as inevitable declines in cognitive and neurological function that 
occurred with aging. Recent research has revealed, however, that these diseases have 
molecular bases allowing potential clinical intervention. The groundbreaking discoveries 
have been made using differing model organisms, which can replicate the phenotype 
and physiological cause of these disorders. One major model organism that has been 
used is the fruit fly, Drosophila melanogaster.  They have served various roles in 
elucidating gene pathways and neurophysiological bases seen in these diseases. 
Current research using Drosophila is attempting to further characterize the molecular 
basis along with potential clinical treatments. These new in-depth studies are in part a 
result of advancing methodologies, which allows greater flexibility in the types of 
experiments that can be done with Drosophila.  
 
Introduction 
1.1 Summary of major neurodegenerative disorders  
Some of the major neurodegenerative diseases researched today are Alzheimer’s 
disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD). They each 
have their own known pathophysiology along with symptomatic presentation. 
AD is a disease that normally appears in those over the age of 65. One of its initial 
symptoms is memory deficit. As the disease progresses, other symptoms begin to 
develop such as aphasia, motor dysfunctions, emotional liability, etc. The accumulations 
of amyloid beta proteins and tau proteins are considered to be the primary causes of 
AD. The toxic amyloid beta originates from cleavage of its precursor protein, APP, by 
gamma secretase. The amyloid beta fragments then stick together to form plaques, 
which activate the immune system causing inflammation and thus neural cell death. Tau 
protein, which normally plays a role in regulating microtubules in brain cells, can 
become hyperphosphorylated and lose its biological function. This lack of microtubule 
regulation can lead to degradation of the synapses along with other cellular issues1. 
 
 
Figure 1. Figure demonstrating cleavage of APP by beta, and then gamma secretase 
leading to amyloid beta fragments. Image obtained from Zhang et al 2 
PD is a disease characterized by motor deficits that also typically appears in elderly 
individuals. The motor defects are one of the primary symptoms that have been 
researched and observed, but there are multiple other non-motor symptoms as well. 
These include cognitive declines, sleep disruptions and problems with autonomic body 
functions. The cause of PD is not well documented, but the loss of dopaminergic 
neurons in the substantia nigra tends to be observed along with lewy body deposition. 
Some factors that are thought to play a role in the development of PD include genetic 
factors, environmental toxins, and other damages to neural tissues causing potential 
protein misfolding. The two major genes believed to be implicated are PINK1 and 
PARKIN, which play a role in triggering autophagy due to damaged mitochondria3,4.  
HD is another neurodegenerative disease characterized by movement deficits that 
usually develops in people in their 30’s to 50’s. The primary symptoms are motor 
deficits that include loss of coordination and involuntary movements. Similar to PD, non-
motor symptoms also begin to appear such as depression and other cognitive effects. 
The genetic basis of HD is known to involve more than 36 CAG trinucleotide repeats in 
the huntingtin (HTT) gene, which interferes with protein function and the subsequent 
neural degeneration. Not much is currently known about the normal function of 
huntingtin protein5.  
 
 
1.2 The Drosophila model  
Drosophila melanogaster is an arthropod that is most commonly known as the fruit fly. 
In the wild, they seek out rotting fruit or other plant matter, which they spend time 
feeding on, and is the location where females eventually lay hundreds of eggs. The 
eggs then hatch into a larval state after a period of 18-24 hours. The larva move around 
and feed on where they were lain for about 4 days, and then subsequently enter a pupal 
stage. The pupal stage lasts another 4 days, and then an adult emerges from the pupae 
and lives around 40 to 120 days 6. 
 
  
Figure 2. Figure demonstrating images of different stages of the lifecycle as obtained 
from Fernández-Moreno et al6 
D. melanogaster contain 4 chromosomes along with 13,600 genes. 2 of the 
chromosomes which D. melanogaster contain are sex chromosomes, with XY resulting 
in a sex of male, and XX resulting in a sex of female. Drosophila show sexual 
dimorphism, with males being slightly smaller, having a dark bottom, and containing 
hairs on their forearms called “sex combs.” Females are larger and are striped all the 
way down their bottom. Unlike in mammals, where females undergo random X-
chromosome inactivation to compensate for their double X chromosomes, in D. 
melanogaster, males undergo X hyperactivation in which their x chromosomes 
produces twice as much transcript7.  
Drosophila are commonly used in the study of genetics, pathology, and neuroscience 
due to the reasons listed above. They are cheap, and easy to maintain (only needing to 
be kept in vials containing a source of food). Their means of reproduction and small 
number of chromosomes enables easy genetic manipulation and a large group of 
offspring containing a desired genotype. Their relatively short lifespan allows for 
phenotypes to be observed throughout development, including degenerative 
phenotypes in later stages of development. Due to D. melanogaster’s widespread use 
as a model organism, much of their anatomy and genes are well characterized, allowing 
in-depth studies on specific functions8.  
1.3 Drosophila Neurodegenerative models 
Drosophila have additionally emerged as a predominant model organism used for the 
study of neurodegenerative diseases along with C. elegans. Anatomically, the nervous 
system of D. melanogaster is well documented, with different cellular lineages such as 
the mushroom body (aids in learning and memory) having specific genes and protein 
products that are well known. Additionally, the neurophysiology is relatively similar to 
humans, with communication between neural synapses being a result of 
neurotransmitters such as GABA, acetylcholine, etc. There are also behaviors that 
Drosophila exhibit relative to learning and memory that serve as parallel to human 
behaviors, allowing for observations of specific deficits. Finally, there are many 
Drosophila homologs to human genes observed in diseases. This allows for the 
manipulation of the paralogs and subsequent phenotype observation9.  
Their genetic makeup, along with various human homologs, are commonly exploited for 
the use of neural research. The genotype can be manipulated to observe the resulting 
phenotype via a change in the expression or mutation of already existing genetic 
homologs, the insertion of human genes known to cause neural disease, or through the 
insertion of RNAi suppressors to modify gene expression. The insertion of human 
disease genes can be used to create many neurodegenerative models. For example, 
there can be an amyloid beta gene inserted to model AD, or an HTT mutant inserted to 
model HD9.  
One of the major ways this is achieved is through the elav-Gal4/UAS system. Elav 
(embryonic lethal abnormal visual) is a RNA-binding protein that is present in the 
nervous system of Drosophila throughout its development10. Gal4 is a yeast derived 
transcriptional activator protein that contains no normal targets in flies and is inserted 
into Gal4/UAS models. UAS (upstream activation sequence) is an enhancer region that 
is activated by the transcriptional activator protein Gal4. In this transgenic setup, one 
parental line will have the elav-Gal4 gene, whereas the other line will have a UAS 
paired with the gene being expressed. When the lines are crossed, the ELAV protein 
will drive the Gal4 expression in the nervous system. The Gal4 will subsequently bind to 
the UAS enhancer causing the expression of the desired gene. These transgenic lines 
are usually produced at lab supply centers such as Bloomington stock, but can also be 
generated in lab via insertion of the desired vector into embryos11. 
The neurodegenerative D. melanogaster models demonstrate various phenotypes that 
can be indicative of the resulting neurodegeneration. One of the most general 
observable phenotypes is a reduced lifespan, which is caused by increased levels of 
toxic proteins that lead to neurodegeneration. Another observable phenotype is a 
decrease in motor function, caused by motor regions of the CNS being deteriorated. 
This can be demonstrated in Drosophila via the use of “negative geotaxis assays,” 
which take advantage of Drosophila’s tendency to move against gravity. When 
significant motor degeneration has occurred, the flies can be observed failing to move 
up to the top of their containers as they normally would. Another observable phenotype 
from neurodegeneration is a loss of memory and learning. This can be observed in 
Drosophila models via courtship assay’s, which measure a male’s ability to remember 
and learn from rejection12.  
To conduct further research to elucidate functions related to specific neurodegenerative 
pathologies, additional manipulation of models will usually take place. To develop a 
further understanding of genetic interactions, additional genes can be inserted or 
manipulated into well-established models. For example, a gene expected of preventing 
neurodegeneration can be upregulated in an AD model and compared with the control 
AD model to observe its effect. To check for potential external factors involved in 
pathology, lifestyle changes can be enacted on the Drosophila such as prevention of 
sleep in a PD model. Additionally, potential therapeutics can be tested by adding them 
to food and then observing phenotype changes of the experimental group versus the 
model.  These manipulations are a few of the examples that are currently being used by 
researches in the field to find the biological basis behind neurodegeneration.  
 
2. Current Research Breakthroughs Using Drosophila  
2.1 Autophagy  
Autophagy is one of the mechanisms through which damaged cells and tissues are 
removed in multicellular organisms. This process has been demonstrated to have an 
important relationship with neurodegeneration, as cells containing toxins, damage, or 
misfolded proteins can be safely discarded in non-pathological tissue. The general 
mechanism of autophagy involves lysosomal digestion of the cell through 3 differing 
mechanisms. The first is chaperone-mediated autophagy, where specific proteins with 
defects are identified and then marked and sent to the lysosome for digestion. This 
mechanism allows for specific proteins with deficits to be disposed of. The next major 
form of autophagy is microautophagy, which is characterized by the lysosome directly 
taking up specific parts of the cell. This allows for specific areas of the cell that may 
contain toxins to be disposed of. The final major type of autophagy is macroautophagy, 
which is characterized by the formation of the autophagosome which fuses with the 
cell’s lysosome. The resulting autolysosome then allows for its contents to be broken 
down. This process is the major one that research is currently being done on in relation 
to neurodegeneration13. 
  
Figure 3. A figure demonstrating the major autophagic processes as described above. 
Obtained from Mizushima et al14 
It is currently being discovered that autophagy plays a key role in the maintenance of 
the nervous system. Some of the major aspects of neurons that are maintained by 
autophagy and found to be important in the degradative process are defective 
mitochondria and proteins found in the axon and synapse. The defective proteins found 
in the synapse and axons can be observed in neurodegenerative disease such as AD, 
where the mutant Amyloid beta and tau protein accumulate13. 
As genes that are critical for autophagy in the nervous system are being investigated, 
they are being found to play a role in neuronal aging as well as degeneration. One of 
the major classes of genes being looked into are the Atg genes13. This family of genes 
contains proteins that form complexes with each other that play a role in the 
development of the autophagosome. Deficits in these genes can hinder the formation of 
the autophagosome and cause neuronal degradation and shortened lifespan, with one 
known example being Atg115. Additionally the loss of Atg5 or Atg7 in Drosophila leads to 
a similar histology (protein aggregates, neurodegeneration) and phenotype (climbing 
defect, memory defects, and shortened lifespan) to that which is typically seen in 
neurodegenerative models16. 
Another gene pathway involved in autophagy that is currently being demonstrated to 
have a relationship with neuronal maintenance are SNARE proteins13. SNARE proteins 
are proteins that play an important role in vesicle fusion. One of the SNARE genes 
investigated to play a role in autophagy is Syx17 (Syntaxin 17). The Drosophila Syx17 
mutants were found to have reduced locomotive ability along with shortened lifespans, 
similar to that seen in neurodegenerative models. With the Syx17 mutants, there was an 
observed accumulation of autophagosome along with protein aggregates seen in the 
CNS17.  
Another study demonstrating the role of autophagy in neuronal maintenance looks at 
the effects of upregulating autophagy on nervous system health. It was found that 
enhancing the level of Atg8 protein in adult Drosophila resulted in effects such as 
enhanced lifespan and a reduced presence of protein aggregates. The average adult 
lifespan increased about 56% as compared to a non Atg upregulated control, and a 12 
fold reduction in protein aggregates was observed. Additionally, upregulated autophagy 
was found to increase the neural resistance to reactive oxidative species, which is a 
major known risk factor for neural degeneration18.  
2.2 Mitochondrial changes 
Mitochondria have been found to function in the pathology of various neurodegenerative 
diseases, with some type of mitochondrial dysfunction being noted in the 3 that are 
discussed. Mitochondria typically function in neurons by carrying out energy production, 
metabolism of nutrients, senescence, and eventual apoptosis or necrosis of neurons19. 
Some of the mechanisms being investigated related to a mitochondrial role in 
neurodegeneration include a problem with mitochondrial fusion/fission, alterations to 
mitochondrial metabolism, calcium homeostasis, and regulation of cell 
death/autophagy20. 
In PD, an impairment to the complex I region of the mitochondria has been observed. 
This affects the mitochondrial ability to carry out dopaminergic cell death, as well as 
increases the amount of free radicals that are found in neurons. The defect with the 
complex I region of the mitochondria leads to a higher number of free radicals within the 
cell, requiring heightened activation of the antioxidant system to reduce the levels to 
normal. The increased presence of ROS can cause reactions and change the formation 
of important cellular molecules like lipids that constitute the membrane along with 
various cellular proteins. The damage to these cellular components leads to the neural 
degeneration seen in PD and other similar diseases21. 
Calcium homeostasis is an important part of normal cellular functions. Additionally, high 
levels of calcium found in the cell can lead to cell death. The mitochondria play an 
important role in buffering intracellular calcium levels through calcium uptake. 
Mitochondrial dysfunction along with calcium dysregulation has been observed in 
various neurodegenerative disorders such as AD, PD, and HD. Defects in the ER-
mitochondrial contact sites are also frequently observed in these diseases. In AD, 
problems with calcium maintenance and mitochondria appear before any obvious 
protein aggregates. Additionally, neurons in AD models were shown to have an 
increase in ER/Mitochondrial connections. For PD, some of the major genes such as 
Parkin and PINK1 have roles in maintaining calcium homeostasis. While there is shown 
to be a relationship between calcium homeostasis and neurodegeneration, an exact 
mechanism is still unknown22. Current research is looking into the specific mechanisms 
through which calcium dysregulation causes the aforementioned changes in 
neurodegeneration. For example, Popugaeva et al23 delves deeper into the specific 
proteins that require proper calcium levels for homeostasis and the resulting effects of 
dysregulation. In AD, these include the development of toxic protein plaques, synaptic 
weakening, etc.23. 
As discussed above in 2.1, autophagy and cell death can serve important roles in 
preventing the build-up of dysfunctional cells and toxic proteins. However, if the process 
of cell death is not regulated properly, healthy cells and tissue can die. This can be in 
part due to the failure of the mitochondria in regulating calcium levels, leading to an 
increase in reactive oxygen species, and thus cell death. It appears that defects with the 
mitochondrial calcium uniporter has a relation to neurodegeneration from oxidative 
stress24. 
 
Figure 4. A figure demonstrating the role of the mitochondrial calcium uniporter in the 
cell. This is one of the mechanisms by which mitochondria regulate calcium in a healthy 
cell. Image obtained from Kannurpatti25 
 
2.3 Synaptic degeneration  
One of the major hallmarks seen in any neurodegenerative disease is a decline is 
synaptic processes. Synapses in a healthy CNS work to allow communication between 
neurons and thus allow the CNS to function as a whole. In most neurodegenerative 
illnesses, even before cell death is observed, there are changes seen in synapses. 
These include a decrease in the amount of individual synapses, alterations to synaptic 
structure, and changes to both pre and post synaptic structures. These changes can be 
seen in various diseases such as AD, PD, and HD26. 
Synaptic function plays a key role in memory, which is one of the most obvious deficits 
in AD patients and models. One of the proposed mechanisms by which synaptic 
function can be dysregulated in AD models involves the improper activation of microglial 
cells. These cells normally play an important role in the neurological immune system 
and function to remove damaged neurons. When they are exposed to amyloid beta, it is 
thought that they function incorrectly and can degrade important synaptic structures27. 
Another mechanism for the early development of memory deficits is the reduction in 
gene expression of proteins important for synaptic transmission. This is thought to occur 
with the expression of amyloid beta28. 
In non-pathological neurons, the proteins PINK1 and PARKIN work together to cause 
the degradation of damaged mitochondria. When PINK1 is mutated, as seen in PD, the 
failing mitochondria cannot be removed. As mentioned in 2.2, mitochondrial defects can 
lead to an accumulation of ROS, dysregulation of calcium homeostasis, along with 
energetic deficits of the cell. While extreme accumulations of defective mitochondria can 
result in inappropriate neuronal death, synaptic function can also be hindered with minor 
levels of mitochondrial dysfunction. This is due to the high reliance of synaptic release 
of neurotransmitters on mitochondria-regulated processes. The packaging of 
neurotransmitters into vesicles and eventual exocytosis requires a large amount of ATP. 
Additionally, calcium is the ionic trigger which signals the release of neurotransmitters. 
When there is calcium dyshomeostasis and energetic deficits due to dysfunctional 
mitochondria, communication is hindered at the synapses. In Doktór et al3, they further 
demonstrate that Drosophila PINK1 mutations lead to a decrease in the presynaptic 
protein BRP, which aids in the accumulation of calcium channels for neurotransmitter 
release3.   
The Htt protein’s primary functions in non-pathological tissues are not well documented. 
It is known that HTT can be found on some membranes and plays a role in endocytosis. 
In Akbergenova and Littleton29, an increase in synaptic connections was noted due to 
an increase in BMP signaling. They attributed the increase in BMP signaling to 
pathogenic Htt blocking the termination of the BMP receptor. The pathologic Htt is seen 
to prevent proper exchange of vesicles at the synapse in Drosophila models. This leads 
to an inability for communications between neurons or at the neuromuscular junction29. 
 
2.4 Summary of current research direction  
The bulk of neurodegenerative research in Drosophila is looking into genes related to 
specific disease processes. These include studies into the prevalence of certain 
phenotypic deficits, histological changes, and molecular changes. While these studies 
typically attempt to elucidate specific disease mechanisms, there are some 
commonalities found between the different neurodegenerative disorders. These 
common traits present in different ways in each disease as noted above. Despite the 
differences, the connections between the mechanisms of disease progression can be 
used to draw conclusions about overall neurodegenerative disease progression.  
There are extensive studies in Drosophila to expand upon the exact mechanisms and 
genetic involvement seen in the varying neurodegenerative disorders. One of these 
areas of research involves the progression of cell death, which is a crucial hallmark of 
all neurodegenerative diseases. This has been demonstrated to occur via various 
processes in the major neurodegenerative diseases. In AD, one of the primary causes 
of neuronal cell death is related to build ups of toxic protein. In PD, damaged 
mitochondria can abnormally signal the process of cell death. Finally, in HD there is 
some dysregulation of the autophagic process observed causing inappropriate cell 
death30. In addition to neuronal death being observed in these diseases, there is similar 
mechanistic pathways through which they progress. One of the most common vectors 
of progression involves dysregulated autophagy. This can cause an excessive amount 
of cell death in cells with accumulated toxic proteins or mitochondrial deficits. It can also 
cause a lack of autophagy in cells that are damaged, leading to a buildup of defective 
cells. These pathways of degeneration are linked to the mitochondrial dysfunction and 
calcium dyshomeostasis as outlined above.   
Research on Drosophila is also currently looking into mitochondrial function in 
neurodegenerative diseases. Again, the specific mechanisms vary between the different 
diseases in the cause of mitochondrial-based degeneration. The major processes that 
are thought to be involved are alterations to aerobic metabolism causing ROS buildups, 
calcium dysregulation, and also their role in autophagy. Current research is looking into 
the specific gene pathways that are involved in the pathologic processes. The general 
findings that are noted include the discovery that the mitochondria can be the key 
source of the problems found in the other areas of pathological problem. The 
mitochondria play key roles in mediating cell death. Calcium, which is regulated by 
mitochondria, plays a role in abnormal neural death as well as autophagy. Additionally, 
mitochondria are being researched due to their importance in proper synaptic function. 
When there is a dysfunction in mitochondria, synapses are one of the first areas of the 
nervous system to begin showing deficits.  
Synaptic function is an additional major area of research currently being conducted. 
This is partially due to the importance of synapses to the function of memory and neural 
health, which is shown to decline in the different neurodegenerative diseases. Many 
separate studies into differing sources of neurodegeneration demonstrate some form of 
synaptic dysfunction. Current research is looking into the different regions of the 
synapses that are the source of the issue. It has been found that presynaptic structures, 
and release of vesicles cannot function properly with dysfunctional mitochondria. Also, 
specific genes have found to be important in the release of the synaptic vesicles, and 
the receiving of neurotransmitters from the previous neuron. Dysfunctions in any of 
these processes can lead to improper neuronal communication.  
  
2.5 Therapeutic applications  
Treatments and therapeutics have historically been limited in neurodegenerative 
disorders due to a limited understanding of the diseases’ molecular mechanisms. 
Recent research is helping to break down this barrier, and open the doors for studies 
into different therapeutics. While for most neurodegenerative diseases a complete 
remedy is still far off, different therapeutics are still being developed now. These 
therapeutics would work by interfering with the pathological processes that are being 
discovered in currently evolving research.  
In AD, there has been a large amount of focus on the amyloid beta pathway of neural 
degeneration. This has led to a focus on development of anti-amyloid beta drugs, which 
have not demonstrated much success in symptomatic relief. One major therapeutic 
possibility involves intervention in the calcium pathway. The excessive calcium 
presence leads to weakened synapses through long term depression mechanisms. This 
is responsible for some of the memory loss observed in AD patients, and is an early 
hallmark for AD. Popugaeva et al23 proposes several different therapeutic approaches 
based on the different levels of calcium dyshomeostasis as a result of ER leak 
channels. One of these includes direct inhibitor treatments of the membrane protein 
responsible for the calcium leak. It also proposed potential treatments to the 
downstream proteins that are affected by the abnormal calcium levels23. 
Understanding the function of certain proteins that are found in neurodegenerative 
diseases is crucial for furthering research into therapeutic possibilities. One protein that 
is currently being researched for its relation to Lewy Body Dementia, AD, and PD is 
alpha synuclein. Alpha synuclein has been shown to aggregate and form Lewy bodies, 
which are found in the progression of PD. Accumulations of this protein are additionally 
found in various types of neurons in PD patients and models31. Alpha synuclein, along 
with the other known PD genes such as PINK1 and Parkin, have been demonstrated to 
participate in mitochondrial function and clearance. Specifically, alpha synuclein has 
recently been observed interacting with Miro, which is a protein that is required to be 
removed from the outer mitochondrial membrane before mitophagy can be initiated. 
Mitophagy is an important process for disposing of damaged mitochondria. This is 
important for neurons due to the reasons discussed in 2.2, as damaged mitochondria 
can quickly cause problems with proper neural functioning. When alpha synuclein 
beings to accumulate, Miro protein has been found to be upregulated. When the 
expression of Miro is downregulated in Drosophila PD models, a significant decline in 
both locomotive defects and neurodegeneration was observed. This demonstrates that 
a therapeutic that works to reduce alpha synuclein (and thus Miro) could aid in reducing 
degradation seen in PD32. 
In HD, mutant HTT plays a large role in the progression of the disease. It has a toxic 
effect on neurons, causing eventual neurodegeneration. After mutant HTT is produced, 
it undergoes many changes that play a role in its toxicity and function in the neurons. 
One of these changes include ubiquitination, a process that normally functions in 
marking the degradation of a protein within the cell. Ubiquitin proteasome system is a 
protein that plays a role in ubiquitination and the autophagy clearance pathway. When 
this is protein is stimulated, autophagy can occur in cells containing toxic proteins. This 
allows for neurons to clear toxic cells that can spread neurodegenerative proteins. Other 
proteins that play a role in the autophagic process could serve to aid in treating HD, 
along with other neurodegenerative disorders33. 
 
3. Current Research Methodology in Drosophila research  
3.1 Transgenic lines 
Drosophila have been used to obtain a large portion of the above information, and are 
one of the crucial models for neurodegenerative research. Before determining specific 
pathways by which the diseases progress, a common model had to be established. 
Drosophila research is heavily dependent on having a common model for which to base 
studies on particular diseases. These models are achieved through various types of 
transgenic lines. These transgenic lines can be generated in a lab via vector insertion 
and crossing, or more commonly received from a stock center that creates specific 
models. One of the frameworks through which neurodegenerative Drosophila models 
are typically created is the Elav-gal4 uas line which is discussed above in 1.3. This 
general outline of the processes of transgenic lines include inserting a gene that 
produces proteins known to be heavily involved in the production of neural deficits. 
These genes’ expression are then driven by tissue specific transcription factors, which 
allow expression in desired tissues. Key genes have generally been used for each 
disease model, however there are variants of each gene which produce slightly different 
pathologies34. 
The primary type of gene insertion for HD models include HTT genes with CAG repeats. 
The main types of variation that is found in the inserted genes in transgenic HD lines 
involves varying amount of glutamine repeats. The different amounts of variations cause 
phenotypic variations in severity, onset, as well as differences in the eye structure. 
Overall, Drosophila HD models tend to display a decrease in motor function, and 
shortened lifespan. In addition to just the HTT protein, some common models include 
different protein expressions that are thought to interact with the HD pathway. These 
include chaperone proteins that can either alleviate or worsen the phenotype, as well as 
proteins that play a role in autophagy35.  
Models for AD in Drosophila typically include some variation of the amyloid beta protein 
or tau combined with the Elav-gal4 model. The amyloid beta gene that is included in the 
transgenic lines is typically a directly toxic variant of amyloid beta such as amyloid beta 
42 or 40. It can also be the precursor of which this toxic protein is formed. This includes 
an APP protein and the gene that encodes for the enzyme that cleaves it into its toxic 
variant, beta-secretase or BACE. This can be used to observe pathways that involve the 
formation of amyloid beta. Another gene that is inserted to generate the transgenic lines 
is tau, which can be included with the amyloid beta genes. Additional variant models 
include genes thought to have some relationship to the development including ApoE 
and presenilin. When these genes are inserted or crossed into the Elav-gal4 model, 
similar neurodegenerative declines to the amyloid beta models are observed36. 
Similar to the other neurodegenerative models, PD in Drosophila is modeled through 
inserted genes that produce a similar phenotype to human PD. These genes include 
multiple mutant variants of “PARK” with some of the significant ones being SNCA, 
parkin, Pink1, DJ-1, and LRRK2. They all induce similar phenotypes and cause 
increased ROS and mitochondrial damage, but with differences among the mechanisms 
through which they function. The phenotypes of these different PD models usually 
include locomotive defects, shortened lifespan, wing muscle weakening, dopaminergic 
neuron loss, and sometimes retinal degeneration21. 
 
3.2 Further Manipulation of Models 
The above models are the origin of how to replicate the diseases in Drosophila. In order 
to conduct research on molecular mechanisms in Drosophila, additional manipulation of 
the models is required. Researches do this via physical manipulation of the model, the 
introduction of external substances, or further genetic manipulation. Further physical 
manipulation could include exposure to exercise or increased darkness. The 
introduction of external substances could include the addition of alcohol in the food of a 
PD model. Finally, further genetic manipulation could include the insertion of an RNAi 
vector to observe the downregulation of another gene. All of these methods help to 
elucidate further processes behind the disease. These manipulations are then paired 
with subsequent observation of molecular and phenotypic changes to demonstrate what 
processes are being affected.  
Varying physical factors has long been used as a method to observe phenotypic 
changes in model organisms. These factors are important as they represent normal 
behavioral variations in disease progression that would normally be seen in humans. 
Researchers have developed creative methodologies to achieve these same variation in 
animal models. One example of this type of manipulation is seen in the blue light 
experiments of Nash et al37. In this study, Drosophila were exposed to a different light 
conditions and subsequent neurodegeneration was observed. Another example of 
physical factor manipulation is seen in the exposure to exercise as seen in Berlandi et 
al38. This study utilized a “swing boat” to expose groups of Drosophila to exercise, and 
then observed a subsequent relation to changes in neurodegeneration.  
 
 
Figure 5. Figure depicting the Swing Boat as used in Berlandi et al38 
The inclusion of external substances to neurodegenerative Drosophila models is 
another important consideration. These inclusions are important to test the effects of 
chemicals in disease progression that humans are normally exposed to. These can 
include chemical exposures to substances such as pesticides in PD, or a study looking 
to connect alcohol with neurodegeneration. These types of experimental modifications 
are also important for the testing of potential therapeutics. The addition of potential 
therapeutics and subsequent observation can be used to further expand upon disease 
processes, or demonstrate substances that could be beneficial. These external 
substances are typically given to the models through their food. An example of a study 
that uses this type of manipulation is Mattioli et al39, in which Drosophila are given food 
containing a plant extract containing polyphenols. 
Another type of alteration made to Drosophila models is further genetic manipulation, 
where genetic expressions in the model are modified to help elucidate cellular pathways 
and related genes. This is achieved through direct changes to genes, insertion of 
additional genes, or alteration of gene expression through RNAi.  Changes to genes 
could include site directed mutagenesis in which individual nucleotides can be altered. 
Including additional genes in the lines can elicit phenotypic changes with interactions 
between the inserted genes, such as including tau in the amyloid beta models. Finally, 
alterations of gene expression through RNAi allows the monitoring of specific native 
genes relating to disease progression. This method is used in Abul Khair et al40, in 
which an RNAi knockdown of a glucocerebrosidase gene is included in a PD model. 
The resulting molecular and phenotypic changes in relation to control PD models was 
then observed.  
 
3.3 Methods for Observing Effects of Manipulation  
After the additional changes have been made to the neurodegenerative Drosophila 
models, procedures are carried out to view the changes to the model. These include 
both methods of observing phenotypic changes and molecular changes. To observe 
neurological phenotypic changes, the most common assays done measure the model’s 
locomotive ability, lifespan, and memory. To observe the molecular changes, typical 
molecular lab procedures are carried out including protein analysis, nucleic acid 
analysis, and immunohistochemistry.  
The different assays to observe phenotypic changes are done by taking advantages of 
some of Drosophila’s unique properties. As discussed in 1.3, locomotor assays are 
done to observe any changes to the models motor ability. This is accomplished by 
taking advantage of Drosophila’s negative geotaxis, or movement against gravity. 
Locomotor assays take place by trapping a fly in a container, and then observing the 
amount that can make it to the top within a limited time. In PD, HD, and advanced AD 
models, the locomotive ability of the flies tends to decrease. Memory assays are done 
by taking advantage of the male flies’ ability to learn during courtship. When male flies 
are rejected by female flies that have already mated, they “learn” to stop trying for a 
period of time after, even when exposed to virgin female flies. In models where memory 
loss is present, such as AD models, this learning process is stunted and male flies will 
persist. While these are the fundamentals behind the assays, certain adjustments can 
be made by researchers. These phenotypic assays are performed to observe the 
effects of the model changes discussed in 3.212. 
The molecular procedures are done to directly observe changes to the model’s genome, 
gene expression, or protein presence. The common methods of nucleic acid 
observation include gel electrophoresis of DNA or cDNA from RT-PCR (reverse-
transcriptase-polymerase chain reaction). These are done to verify gene presence. 
Gene expression can then be measured through qPCR or western blots. A combination 
of these methods are typically carried out to observe the relationship between inserted 
genes and their effect on other gene expression or protein presence. This can also be 
taken a step further in immunohistochemistry. In neurodegenerative Drosophila models, 
this is typically done by creating thin slices of the brain and then staining with specific 
antibodies. Proper imaging can then show the protein of interest’s presence in the brain, 
and potential neurodegeneration. These, along with other methods of observing 
molecular changes, are used to verify changes caused by additional factors in the 
disease pathway41.  
 
4. Future Direction of Neurodegenerative Research in Drosophila 
Up to this point, research in Drosophila has greatly expanded the understanding of 
specific neurodegenerative diseases along with the general neurodegenerative process. 
The current research direction consists of an expanding understanding of the processes 
of these diseases and other involved genes. Additionally, there is a push to test for 
potential therapeutics that can help with neurodegeneration and even potentially repair 
damages done. This is a major goal in neurodegenerative disease research among all 
models, as currently used therapeutics only work to target symptoms, rather than 
disease origin. Going forward, there will be further work done to develop a clear cellular 
pathway for the different diseases. Understanding the genes and proteins involved is 
vital for a therapeutic which can hinder or halt disease progression. Although each 
disease has its own genes and origins, current research is demonstrating there may be 
similar pathways among them. One such recently published study reveals that mutant 
HTT protein in HD consists of similar aggregation and properties to the amyloid beta 
protein in AD42. Further studies demonstrating these similar properties will be important 
for a holistic understanding of disease progression. Another future direction of 
neurodegenerative research involves the reversal of neuronal damages. While 
neurogenesis in adult brains only occurs in certain areas43, neuronal processes can 
grow and change throughout adulthood. One aspect of this, axonal regeneration, is 
currently being discussed as a means to maintain synapses despite damages44.  
 
5. Conclusion  
A significant portion of what is known today about the nervous system and the diseases 
that affect it have been obtained from research on D. melanogaster. At a glance, HD, 
PD, and AD may seem to occur via differing mechanisms that occur from various 
genetic causes. From the many studies on neurodegeneration being done by 
researchers from around the world, commonalities are beginning to be drawn between 
the different degenerative processes. These include defects in the neurons ability to 
carry out autophagy, proper mitochondrial function, and synaptic degeneration. While a 
clear connection is not well understood at the time, research is currently being 
conducted to clarify these processes and how to halt them. As Drosophila has proven to 
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